Trial intelligence / Profile preview

De-escalated Adjuvant IMRT Post-Surgery in p16+ Oropharynx Cancer

NCT05388773Phase 2Recruiting

Start
Jul 2022
Primary completion
Dec 2028
Countries
1
01

Overview

A Phase 2 trial of Cisplatin micelle injection (HA132), carboplatin in oropharyngeal cancer. Started Jul 2022; status: recruiting.

02

Drugs

Cisplatin micelle injection (HA132)carboplatin
03

Conditions

oropharyngeal cancer

Beyond the preview

Go deeper on NCT05388773.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05388773.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call